Navigation Links
New drugs faster from natural compounds: A UC San Diego breakthrough
Date:7/13/2009

Researchers have invented computational tools to decode and rapidly determine whether natural compounds collected in oceans and forests are newor if these pharmaceutically promising compounds have already been described and are therefore not patentable.

This University of California, San Diego advance will finally enable scientists to rapidly characterize ring-shaped nonribosomal peptides (NRPs)a class of natural compounds of intense interest due to their potential to yield or inspire new pharmaceuticals. The study will be published in the July 13 online issue of journal Nature Methods.

"These advances will speed the process by which we discover and describe new and biologically active molecules from organisms such as marine cyanobacteria, also known as blue-green algae. This, in turn, will accelerate the timeline for bringing new experimental therapies into clinical application," said William Gerwick, an author on the paper and a professor with the UC San Diego Scripps Institution of Oceanography Center for Marine Biotechnology and Biomedicine and the UCSD Skaggs School of Pharmacy and Pharmaceutical Sciences. (Read about Gerwick's work to discover drugs and protect Panama's natural and cultural resources at: http://explorations.ucsd.edu/Features/2009/Discovering_Diversity/images/07_2009_Feature.pdf )

Nonribosomal peptides (NRPs) often serve as chemical defenses for the bacteria that manufacture them. Starting from penicillin, NRPs have an unparalleled track record in pharmacology: most anti-cancer and anti-microbial agents are natural products or their derivatives. However, it is currently difficult, time-consuming and costly to determine the molecular structure of NRPs which, by definition, are not directly inscribed in the genomes of the organisms that produce them.

"NRPs are one of the last bastions of ph
'/>"/>

Contact: Daniel Kane
dbkane@ucsd.edu
858-534-3262
University of California - San Diego
Source:Eurekalert  

Page: 1 2 3 4

Related biology technology :

1. Global Prescription Drugs Market to Cross $897 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
2. Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August
3. Domain Registration Corp ("BioPharm Asia, Inc") Opens 360 New Drugstores in Jilin and Liaoning Provinces
4. NIMOTUZUMAB DEMONSTRATES EFFICACY IN RANDOMIZED HEAD & NECK CANCER STUDY WITHOUT THE TOXICITIES ASSOCIATED WITH OTHER EGFR DRUGS
5. China Sky One Medical, Inc. Obtains Production Approval for Two New Drugs
6. HealthCore Responds to Need for Real-world Health Outcomes Information on Drugs and Devices with Physician Network and Prospective Effectiveness Research
7. ImQuest BioSciences and Arisyn Therapeutics Announce Strategic Partnership to Develop Infectious Disease and Cancer Drugs
8. NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBays Novel Aganocide Drugs for Major Dermatological Conditions
9. New Insights into the Mechanism of Action of Antipsychotic Drugs
10. Safer nanoparticles spotlight tumors, deliver drugs
11. VAP Cholesterol Test Helps In Search For New Heart Disease Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New drugs faster from natural compounds: A UC San Diego breakthrough
(Date:6/18/2013)... June 18, 2013 ... announced the addition of the report " ... " to their offering.      ... reviews basics of human genome variations, development ... large and small sequencers are described as ...
(Date:6/18/2013)... 2013   Lexicon Pharmaceuticals, Inc. (Nasdaq: ... on discovering breakthrough treatments for human disease, announced ... the company as its vice president of marketing, ... commercial experience to Lexicon, including both pre-launch planning ... areas. Mr. Northcott has held commercial ...
(Date:6/18/2013)... DUBLIN , June 18, 2013 ... Markets ( http://www.researchandmarkets.com/research/cmbgcv/north_american ) has announced ... American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes ... Radiation Therapy (I131, Y-90)], [Applications (Cancer/Oncology, ... to 2017" report to their ...
(Date:6/18/2013)... June 18, 2013 Inflamax Research ... of Concept and Phase I-IV clinical trials, announced ... with Northern Air Environmental Technologies (NAET), a specialty ... deployment, monitoring, and servicing of mobile Environmental Exposure ... clinical trials. , Inflamax Research ...
Breaking Biology Technology:DNA Sequencing: Technologies, Markets and Companies - 2013 Report 2John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 2John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 3North American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Forecast to 2017 2North American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Forecast to 2017 3Inflamax Research Inc. Enters Strategic Partnership with Northern Air Environmental Technologies Inc. 2Inflamax Research Inc. Enters Strategic Partnership with Northern Air Environmental Technologies Inc. 3
... CLAREMONT, Calif.*, May 19 /Xinhua-PRNewswire-FirstCall/ --,Kiwa Bio-Tech Products ... Beijing Hai Xin Science and Technology Co., Ltd.,("Hai ... This,May, the Board Chairman of Hai Xin, Mr. ... Kiwa,s Beijing headquarters., Hai Xin is a ...
... Digital Radiography, PACS and Practice Management Software Adds ... Philips Ultrasound ... Eklin Medical Systems, a,leading developer of digital radiography (DR), ... (VIA(TM)) for,veterinary care practices, announced it has completed its ...
... May 19 Replikins Ltd. has found that ... found in the,trypanosomes that are the infectious agents ... in fact the highest replikin concentrations observed to,date ... also found that these,concentrations cycle over several years., ...
Cached Biology Technology:Kiwa Bio-Tech in Collaboration Discussions with Beijing Hai Xin Science and Technology Co., Ltd. 2Kiwa Bio-Tech in Collaboration Discussions with Beijing Hai Xin Science and Technology Co., Ltd. 3Eklin Announces Acquisition of Ultrasource, Inc. 2Eklin Announces Acquisition of Ultrasource, Inc. 3Highest Replikin Concentrations and Cyclical Behavior Related to Human Mortality Are Found in Malaria Trypanosomes 2
(Date:6/18/2013)... of DNA and this modification can occur in ... now, scientists believed that this epigenetic phenomenon actively ... team of researchers from the University of Geneva ... at the Faculty of Medicine, reveals that this ... methylation may play both a passive and active ...
(Date:6/17/2013)... patients with severe brain infections in Vietnam. Further research ... for the symptoms of disease. , The virus was ... patients with severe brain infections in the study, corresponding ... 122 patients with non-infectious brain disorders that were tested. ... are often fatal and patients who do survive, often ...
(Date:6/17/2013)... improving original foundations with more modern elements. Using this ... Kenneth P. Dietrich School of Arts and Sciences have ... delivery, gas storage, and gas transport more efficient and ... the latest issue of the Journal of the ... recent work builds upon Pitt Associate Professor of Chemistry ...
Breaking Biology News(10 mins):The secret of DNA methylation 2New virus isolated from patients with severe brain infections 2New virus isolated from patients with severe brain infections 3'Chemical architects' build materials with potential applications in drug delivery and gas storage 2
... 13, 2011   Fate Therapeutics, Inc. announced ... trial of ProHema (FT1050-enhanced umbilical cord blood) as ... adult patients with hematologic malignancies who have undergone ... at the 53rd annual American Society of Hematology ...
... least one person admits that the extreme heat in Texas this year ... a handmade torture chamber. ... about the heat, but from my viewpoint as a breeder, I love ... maximum mean highs of 107 degrees for weeks near Mansfield and 104 ...
... have found an explanation for how the intestinal tract ... prevent infection, offering a potential clue to the cause ... "The findings shed light on the complex balance ... Prof. Jennifer Gommerman, an Associate Professor in the Department ...
Cached Biology News:Fate Therapeutics Announces Promising Data From Phase 1b Study of ProHema at the 2011 American Society of Hematology Annual Conference 2Fate Therapeutics Announces Promising Data From Phase 1b Study of ProHema at the 2011 American Society of Hematology Annual Conference 3Fate Therapeutics Announces Promising Data From Phase 1b Study of ProHema at the 2011 American Society of Hematology Annual Conference 4Rose torture: severe heat in Texas yields better varieties for research 2Intestine crucial to function of immune cells, research shows 2Intestine crucial to function of immune cells, research shows 3
... contains 4 deuterium atoms at the 9, 10, ... use as an internal standard for the quantification ... is produced by the lipoxygenation of linoleic acid ... detected in atherosclerotic plaques, as an esterified component ...
5(S)-HETE-d8 is used as an internal standard for the quantification of 5(S)-HETE by stable isotope dilution mass spectrometry....
...
All-in-one mix, removes primers and dNTPs from PCR product for following direct sequencing...
Biology Products: